Aragon Pharmaceuticals Receives $22,000,000 Series B Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f63a0b96-de96-4815-837a-947ab4dea4a7&Preview=1
Date
4/23/2010
Company Name
Aragon Pharmaceuticals
Mailing Address
4215 Sorrento Valley Blvd. San Diego, CA 92121
Company Description
Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers.
Website
http://www.aragonpharmaceuticals.com
Transaction Type
Venture Equity
Transaction Amount
$22,000,000
Transaction Round
Series B
Proceeds Purposes
This financing will allow us to advance ARN-509 into clinical trials and continue the discovery and development of selective androgen receptor degraders and selective estrogen receptor degraders for the treatment of prostate and breast cancers.
M&A Terms
Venture Investor
Aisling Capital
Venture Investor
OrbiMed
Venture Investor
The Column Group